Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Suttorp

Showing results (241-250 of 278) with videos related to

Pageof 28
Sort By:
The European Respiratory Journal|November 6, 2020
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failureLaura Michalick, Sarah Weidenfeld, Benjamin Grimmer, et al.
European Journal of Heart Failure|May 1, 2021
Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findingsSara Hadzibegovic, Alessia Lena, Timothy W Churchill, et al.
The Lancet. Respiratory Medicine|August 15, 2021
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort studyDavid Hillus, Tatjana Schwarz, Pinkus Tober-Lau, et al.
Kidney International Reports|April 5, 2021
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19Jan-Hendrik B Hardenberg, Helena Stockmann, Annette Aigner, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2017
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac RemodelingLuis F Reyes, Marcos I Restrepo, Cecilia A Hinojosa, et al.
Science Translational Medicine|December 8, 2022
Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiationLasti Erfinanda, Lin Zou, Birgitt Gutbier, et al.
Critical Care Medicine|January 4, 2018
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2Birgitt Gutbier, Stefanie M Schönrock, Carolin Ehrler, et al.
Infection|April 7, 2021
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severityJan-Moritz Doehn, Christoph Tabeling, Robert Biesen, et al.
Respiratory Medicine|September 9, 2022
Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescentsFridolin Steinbeis, Philipp Knape, Mirja Mittermaier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2025
Predicting the Risk of Intensive Care Unit Admission in Patients With COVID-19 Presenting in the Emergency Room: Development and Evaluation of the Confusion, Respiratory Rate, Oxygen Saturation With or Without Concurrent Supplemental Oxygen, and Oxygen Supplementation ScoreWeiwei Xiang, Fridolin Steinbeis, Kiret Dhindsa, et al.
Pageof 28

Showing results (241-250 of 278) with videos related to

Sort By:
Pageof 28
The European Respiratory Journal|November 6, 2020
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failureLaura Michalick, Sarah Weidenfeld, Benjamin Grimmer, et al.
European Journal of Heart Failure|May 1, 2021
Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findingsSara Hadzibegovic, Alessia Lena, Timothy W Churchill, et al.
The Lancet. Respiratory Medicine|August 15, 2021
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort studyDavid Hillus, Tatjana Schwarz, Pinkus Tober-Lau, et al.
Kidney International Reports|April 5, 2021
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19Jan-Hendrik B Hardenberg, Helena Stockmann, Annette Aigner, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2017
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac RemodelingLuis F Reyes, Marcos I Restrepo, Cecilia A Hinojosa, et al.
Science Translational Medicine|December 8, 2022
Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiationLasti Erfinanda, Lin Zou, Birgitt Gutbier, et al.
Critical Care Medicine|January 4, 2018
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2Birgitt Gutbier, Stefanie M Schönrock, Carolin Ehrler, et al.
Infection|April 7, 2021
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severityJan-Moritz Doehn, Christoph Tabeling, Robert Biesen, et al.
Respiratory Medicine|September 9, 2022
Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescentsFridolin Steinbeis, Philipp Knape, Mirja Mittermaier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2025
Predicting the Risk of Intensive Care Unit Admission in Patients With COVID-19 Presenting in the Emergency Room: Development and Evaluation of the Confusion, Respiratory Rate, Oxygen Saturation With or Without Concurrent Supplemental Oxygen, and Oxygen Supplementation ScoreWeiwei Xiang, Fridolin Steinbeis, Kiret Dhindsa, et al.
Pageof 28